₹ 1.2 Cr
Volume Transacted
(Jan 15, 2025)
5.8 K
Stocks Traded
(Jan 15, 2025)
Last Updated on: Jan 15, 2025
Glaxosmithkline Pharmaceuticals Ltd
BSE
15 Jan, 2025
2043.35-33.8 (-1.6%)
Prev Close
2077.2
Open Price
2134.9
Bid Price (QTY)
Offer Price (QTY)
Volume
5796
Today's High / Low
2134.9 / 2016.0
52 WK High / Low
3087.9 / 1825.1
NSE
15 Jan, 2025
2042.5-29.5 (-1.4%)
Prev Close
2072.1
Open Price
2086.0
Bid Price (QTY)
Offer Price (QTY)
Volume
66252
Today's High / Low
2116.4 / 1987.0
52 WK High / Low
3088.0 / 1842.1
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
14 Jan 2025 | 2077.2 | 2051.5 | 2123.15 | 2051.5 |
13 Jan 2025 | 2090.2 | 2140.3 | 2164.75 | 2080 |
10 Jan 2025 | 2190.05 | 2200.5 | 2207.4 | 2145.25 |
09 Jan 2025 | 2208.75 | 2222 | 2228.65 | 2200 |
08 Jan 2025 | 2207.85 | 2234.95 | 2242.45 | 2184.6 |
07 Jan 2025 | 2230.1 | 2244.95 | 2244.95 | 2190 |
06 Jan 2025 | 2203.2 | 2241.65 | 2246.95 | 2181.4 |
03 Jan 2025 | 2240.85 | 2221.4 | 2249.05 | 2219 |
02 Jan 2025 | 2221.4 | 2243.6 | 2255.95 | 2209.75 |
01 Jan 2025 | 2234.2 | 2252 | 2271.2 | 2223 |
Date | Price (₹) |
---|---|
14 Jan 2025 | 2077.2 |
13 Jan 2025 | 2090.2 |
10 Jan 2025 | 2190.05 |
09 Jan 2025 | 2208.75 |
08 Jan 2025 | 2207.85 |
07 Jan 2025 | 2230.1 |
06 Jan 2025 | 2203.2 |
03 Jan 2025 | 2240.85 |
02 Jan 2025 | 2221.4 |
01 Jan 2025 | 2234.2 |
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Entity | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
---|
Cipla Ltd | -3.3 | -0.0 | -9.5 | -4.5 | 10.3 | 57.2 | 198.9 | 129.4 |
Glaxosmithkline Pharmaceuticals Ltd | -6.9 | -8.9 | -23.7 | -18.6 | -8.0 | 17.8 | 27.6 | 30.1 |
Dr Reddys Laboratories Ltd | -1.0 | 5.3 | 0.3 | -1.6 | 15.6 | 42.6 | 126.9 | 108.5 |
Sun Pharmaceuticals Industries Ltd | -4.6 | -2.3 | -7.4 | 11.5 | 33.1 | 105.6 | 296.8 | 115.5 |
Divis Laboratories Ltd | 1.7 | 2.5 | -3.5 | 31.1 | 53.5 | 30.0 | 220.1 | 605.0 |
Mankind Pharma Ltd | -8.5 | -0.7 | -3.2 | 24.4 | 22.1 | 0.0 | 0.0 | 0.0 |
Entity | 1W |
---|---|
Cipla Ltd | -3.3 |
Glaxosmithkline Pharmaceuticals Ltd | -6.9 |
Dr Reddys Laboratories Ltd | -1.0 |
Sun Pharmaceuticals Industries Ltd | -4.6 |
Divis Laboratories Ltd | 1.7 |
Mankind Pharma Ltd | -8.5 |
Last updated time: 15 Jan 15:30 PM
Parameter | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|
Sales (Cr.) | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
Sales YoY Gr. | - | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Adj EPS | 39.76 | 41.41 | 26.29 | 5.5 | 21.14 | 100.04 | 36.05 | 34.83 |
YoY Gr. | - | 4.2% | -36.5% | -79.1% | 284.4% | 373.2% | -64.0% | -3.4% |
Net Profit (Cr.) | 337 | 351 | 445 | 93 | 358 | 1695 | 611 | 590 |
BVPS | 236.93 | 242.89 | 126.31 | 107.47 | 87.26 | 157.19 | 102.79 | 104.93 |
Parameter | 2017 |
---|---|
Sales (Cr.) | NaN |
Sales YoY Gr. | - |
Adj EPS | 39.76 |
YoY Gr. | - |
Net Profit (Cr.) | 337 |
BVPS | 236.93 |
Parameter | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|
Return on Capital Emp. % | 27.81 | 25.24 | 21.49 | 23.32 | 28.44 | 28.51 | 32.43 | 32.55 | 33.92 | 44.97 |
Op. Profit Mgn % | 22.91 | 21.27 | 17.95 | 19.97 | 23.39 | 22.76 | 24.23 | 25.53 | 27.89 | 28.42 |
Net Profit Mgn % | 13.97 | 13.25 | 11.23 | 12.11 | 14.24 | 6.11 | 16.27 | 51.36 | 18.78 | 19.01 |
Debt to Equity % | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Parameter | 2015 |
---|---|
Return on Capital Emp. % | 27.81 |
Op. Profit Mgn % | 22.91 |
Net Profit Mgn % | 13.97 |
Debt to Equity % | 0 |
No data available
No data available
Unlimited trading starting at just Rs. 249*